Your browser doesn't support javascript.
loading
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.
Álvarez, Eva G; Demeulemeester, Jonas; Otero, Paula; Jolly, Clemency; García-Souto, Daniel; Pequeño-Valtierra, Ana; Zamora, Jorge; Tojo, Marta; Temes, Javier; Baez-Ortega, Adrian; Rodriguez-Martin, Bernardo; Oitaben, Ana; Bruzos, Alicia L; Martínez-Fernández, Mónica; Haase, Kerstin; Zumalave, Sonia; Abal, Rosanna; Rodríguez-Castro, Jorge; Rodriguez-Casanova, Aitor; Diaz-Lagares, Angel; Li, Yilong; Raine, Keiran M; Butler, Adam P; Otero, Iago; Ono, Atsushi; Aikata, Hiroshi; Chayama, Kazuaki; Ueno, Masaki; Hayami, Shinya; Yamaue, Hiroki; Maejima, Kazuhiro; Blanco, Miguel G; Forns, Xavier; Rivas, Carmen; Ruiz-Bañobre, Juan; Pérez-Del-Pulgar, Sofía; Torres-Ruiz, Raúl; Rodriguez-Perales, Sandra; Garaigorta, Urtzi; Campbell, Peter J; Nakagawa, Hidewaki; Van Loo, Peter; Tubio, Jose M C.
Afiliação
  • Álvarez EG; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Demeulemeester J; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Otero P; The Francis Crick Institute, London, NW1 1AT, UK.
  • Jolly C; Department of Human Genetics, University of Leuven, Leuven, B-3000, Belgium.
  • García-Souto D; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Pequeño-Valtierra A; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Zamora J; The Francis Crick Institute, London, NW1 1AT, UK.
  • Tojo M; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Temes J; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Baez-Ortega A; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Rodriguez-Martin B; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Oitaben A; The Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo, 36310, Spain.
  • Bruzos AL; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Martínez-Fernández M; Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK.
  • Haase K; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Zumalave S; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Abal R; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Rodríguez-Castro J; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Rodriguez-Casanova A; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Diaz-Lagares A; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Li Y; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Raine KM; The Francis Crick Institute, London, NW1 1AT, UK.
  • Butler AP; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Otero I; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Ono A; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Aikata H; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Chayama K; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela, 15706, Spain.
  • Ueno M; Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of SantiagodeCompostela(IDIS), Santiago de Compostela, 15706, Spain.
  • Hayami S; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela, 15706, Spain.
  • Yamaue H; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, 28029, Spain.
  • Maejima K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
  • Blanco MG; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
  • Forns X; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
  • Rivas C; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Ruiz-Bañobre J; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, 15706, Spain.
  • Pérez-Del-Pulgar S; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Torres-Ruiz R; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Rodriguez-Perales S; Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Garaigorta U; Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Campbell PJ; RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, 230-0045, Japan.
  • Nakagawa H; Department of Surgery II, Wakayama Medical University, Wakayama, Japan.
  • Van Loo P; Department of Surgery II, Wakayama Medical University, Wakayama, Japan.
  • Tubio JMC; Department of Surgery II, Wakayama Medical University, Wakayama, Japan.
Nat Commun ; 12(1): 6910, 2021 11 25.
Article em En | MEDLINE | ID: mdl-34824211
ABSTRACT
Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Viral / Genoma Humano / Vírus da Hepatite B / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Viral / Genoma Humano / Vírus da Hepatite B / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article